SLy1-deficiency results in functional impaired, exhausted and senescent NK cells

Lisa Rebmann1, Victoria Schwenck1, Carolin Blumendeller1

  • 1Department of Pharmacology, Experimental Therapy and Toxicology, Institute of Experimental and Clinical Pharmacology and Pharmacogenomic and ICePhA, University of Tübingen, Tübingen, Germany.

Abstract

Insights

The adapter protein SLy1 is crucial for natural killer (NK) cell viability and function. Its absence leads to p53-mediated impairments, while also causing NK cell senescence and exhaustion independently of p53.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • SLy1 is an adapter protein essential for lymphocyte function, particularly in NK cells where it stabilizes ribosomes.
  • SLy1 deficiency in NK cells causes ribosomal instability, leading to p53 accumulation and impaired cell function.
  • The precise role of SLy1 and its dependence on p53 in NK cell biology remained unclear.

Purpose of the Study:

  • To investigate the phenotypical and functional characteristics of NK cells deficient in SLy1 and p53.
  • To determine which NK cell impairments are dependent on SLy1 and p53.

Main Methods:

  • Generation of a SLy1(WT/KO); p53(WT/KO) mouse model.
  • Analysis of NK cell viability, cytotoxicity, surface receptor expression, cell numbers, senescence, and exhaustion.
  • Measurement of DNA damage response mediators at protein and mRNA levels.

Main Results:

  • SLy1 deficiency reduces NK cell viability, cytotoxicity, and activating receptor expression, which is mediated by p53.
  • SLy1 deficiency also decreases NK cell numbers and increases senescence and exhaustion, independent of p53.
  • Elevated levels of DNA damage response mediators were observed in SLy1-deficient NK cells.

Conclusions:

  • SLy1 is essential for maintaining adequate numbers of viable, functional NK cells, with p53 mediating key impairments.
  • NK cell senescence and exhaustion occur in a p53-independent manner upon SLy1 absence.
  • Findings suggest SLy1 mutations could be linked to immunodeficiencies, warranting genetic testing.